Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 4

Results For "OSD"

33 News Found

BDR plans to enter the regulated markets this year: Raheel Shah, Director, BDR Group of Companies
interviews | February 15, 2022

BDR plans to enter the regulated markets this year: Raheel Shah, Director, BDR Group of Companies

BDR Pharmaceuticals is a home-grown company with operations in India and overseas. It’s known for its formulations portfolio and has a presence in specialty medicines. The company has ambitious plans as it has ramped up capacity and looking to foray into regulated markets. Raheel Shah, Director, BDR Group of Companies shares his insights in an interview with Thomas C Thottathil, Editor, Indian Pharma Post

Merck acquires Chord Therapeutics to expand its neuroinflammatory pipeline
News | December 22, 2021

Merck acquires Chord Therapeutics to expand its neuroinflammatory pipeline

Acquisition provides opportunity to develop cladribine in generalized Myasthenia Gravis (gMG) and Neuromyelitis Optica Spectrum Disorder (NMOSD)

Piramal Enterprises cashing in on opportunities: ICICI Securities
News | March 02, 2021

Piramal Enterprises cashing in on opportunities: ICICI Securities

PEL will explore the PLI scheme and apply if its beneficial.

Upcoming E-conference
June 19, 2026 The Future of Clinical Research in India: Can India Become a Global Trial Hub?
July 17, 2026 Biosimilars & Biologics: The Next Growth Frontiers for Indian Pharma

Latest Stories

CORONA Remedies receives EU-GMP certification for hormone facility

Marksans Pharma to acquire Netherlands-based QliniQ B.V.

FDA okays AstraZeneca’s bladder cancer drug Imfinzi Plus BCG

White Papers

Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants

Implementing a digital transformation in chemical operations to maximize profitability

The complexity of compliance

The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation

The guiding role of fluidized and spouted bed technologies in particle building processes

Interviews
Expanding our technical portfolio with advanced ICP-OES Series to boost India's analytical capabilities: Santosh Kumar, Managing Director, Analytik Jena India
Expanding our technical portfolio with advanced ICP-OES Series to boost India's analytical capabilities: Santosh Kumar, Managing Director, Analytik Jena India
Empowering life sciences and diagnostics with balanced, scalable technologies: Dev Ananthan, Director of Strategic Marketing, Danaher Lifesciences
Empowering life sciences and diagnostics with balanced, scalable technologies: Dev Ananthan, Director of Strategic Marketing, Danaher Lifesciences
Nexis GC-2060 is Shimadzu's new flagship gas chromatograph system: Dheeraj Handique, Manager - Sales & Marketing, Analytical Division, Shimadzu India
Nexis GC-2060 is Shimadzu's new flagship gas chromatograph system: Dheeraj Handique, Manager - Sales & Marketing, Analytical Division, Shimadzu India

Packaging